A pilot study of clinical cell therapy for patients with vascular dementia

Cui, 2019, Cerebrolysin for vascular dementia, Cochrane Database Syst Rev, 2019 Iadecola, 2013, The pathobiology of vascular dementia, Neuron, 80, 844, 10.1016/j.neuron.2013.10.008 Gorelick, 2016, Vascular cognitive impairment and dementia, Biochim Biophys Acta, 1862, 860, 10.1016/j.bbadis.2015.12.015 Skrobot, 2017, The vascular impairment of cognition classification consensus study, Alzheimers Dement, 13, 624, 10.1016/j.jalz.2016.10.007 Horsburgh, 2018, Small vessels dementia and chronic diseases-molecular mechanisms and pathophysiology, ClinSci (Lond), 132, 851, 10.1042/CS20171620 Kalaria, 2018, The pathology and pathophysiology of vascular dementia, Neuropharmacology, 134, 226, 10.1016/j.neuropharm.2017.12.030 Parfenov, 2019, Vascular cognitive impairment: pathophysiological mechanisms, insights into structural basis, and perspectives in specific treatments, Neuropsychiatr Dis Treat, 15, 1381, 10.2147/NDT.S197032 Volkman, 2017, Concise review: mesenchymal stem cells in neurodegenerative diseases, Stem Cells, 35, 1867, 10.1002/stem.2651 Yao, 2018, Olfactory ensheathing cells for spinal cord injury: sniffing out the issues, Cell Transplant, 27, 879, 10.1177/0963689718779353 Lu, 2017, Differentiation of human olfactory mucosa mesenchymal stem cells into photoreceptor cells in vitro, Int J Ophthalmol, 10, 1504 Turner, 2006, Factitious disorders: reformulating the DSM-IV criteria, Psychosomatics, 47, 23, 10.1176/appi.psy.47.1.23 Uysal, 2019, ICD-10-CM diagnosis coding for neuropsychological assessment, Arch Clin Neuropsychol, 34, 721, 10.1093/arclin/acy084 Jia, 2010, Discussion on clinical diagnostic criteria of vascular dementia (in Chinese), Chin J Neuroimmunol Neurol, 6, 387 Wang, 2020, Olfactory ensheathing cells in chronic ischemic stroke: a phase 2, double-blind, randomized, controlled trial, J Neurorestoratol, 8, 182, 10.26599/JNR.2020.9040019 Huang, 2020, Standards of clinical-grade olfactory ensheathing cell culture and quality control (2020 China Version), J Neurorestoratol, 8, 217, 10.26599/JNR.2020.9040023 Holbrook, 2011, Immunohistochemical characterization of human olfactory tissue, Laryngoscope, 121, 1687, 10.1002/lary.21856 Stamegna, 2018, Grafts of olfactory stem cells restore breathing and motor functions after rat spinal cord injury, J Neurotrauma, 35, 1765, 10.1089/neu.2017.5383 Bonnet, 2020, Immediate or delayed transplantation of a vein conduit filled with nasal olfactory stem cells improves locomotion and axogenesis in rats after a peroneal nerve loss of substance, Int J Mol Sci, 21, 10.3390/ijms21082670 Huang, 2012, Long-term outcome of olfactory ensheathing cell therapy for patients with complete chronic spinal cord injury, Cell Transplant, 21, S23, 10.3727/096368912X633734 Tabakow, 2014, Functional regeneration of supraspinal connections in a patient with transected spinal cord following transplantation of bulbar olfactory ensheathing cells with peripheral nerve bridging, Cell Transplant, 23, 1631, 10.3727/096368914X685131 Huang, 2009, Olfactory ensheathing cells transplantation for central nervous system diseases in 1,255 patients (in Chinese), Chin J Reparative Reconstr Surg, 23, 14 Zhou, 2012, Transplantation of autologous activated Schwann cells in the treatment of spinal cord injury: six cases, more than five years of follow-up, Cell Transplant, 21, S39, 10.3727/096368912X633752 Saberi, 2008, Treatment of chronic thoracic spinal cord injury patients with autologous Schwann cell transplantation: an interim report on safety considerations and possible outcomes, Neurosci Lett, 443, 46, 10.1016/j.neulet.2008.07.041 Saberi, 2011, Safety of intramedullary Schwann cell transplantation for postrehabilitation spinal cord injuries: 2-year follow-up of 33 cases, J Neurosurg Spine, 15, 515, 10.3171/2011.6.SPINE10917 van Horne, 2018, Peripheral nerve grafts implanted into the substantia nigra in patients with Parkinson´s disease during deep brain stimulation surgery: 1-year follow-up study of safety, feasibility, and clinical outcome, J Neurosurg, 129, 1550, 10.3171/2017.8.JNS163222 Huang, 2020, Clinical neurorestorative cell therapies: Developmental process, current state and future prospective, J Neurorestoratol, 8, 61, 10.26599/JNR.2020.9040009